NCT00800839 Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide Status COMPLETED Phase PHASE2
NCT00794261 Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma Status COMPLETED Phase PHASE2
NCT00698776 Combination of Lenalidomide and Autologous Mature Dendritic Cells Pulsed With KRN7000 in Myeloma Status COMPLETED Phase PHASE1
NCT00660166 Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions Status COMPLETED Phase PHASE1
NCT00606437 Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants Status COMPLETED Phase PHASE1
NCT00597714 Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT00580034 Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath Status COMPLETED Phase PHASE2
NCT00578942 Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath Status COMPLETED Phase PHASE2
NCT00473551 Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies Status TERMINATED Phase PHASE1
NCT00469209 Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00466674 Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning Status COMPLETED Phase PHASE2
NCT00439465 Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00428545 Bevacizumab and Bortezomib in Patients With Advanced Malignancy Status COMPLETED Phase PHASE1
NCT00410982 Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies Status COMPLETED Phase PHASE1
NCT00361140 Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) Status COMPLETED Phase PHASE4
NCT00344422 Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE3
NCT00242827 Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma Status TERMINATED Phase PHASE2
NCT00195533 Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients Status COMPLETED Phase N/A